SCINAI IMMUNOTHERAPEUTICS LTD. Diluted Earnings Loss Per Share
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Diluted Earnings Loss Per Share of -0.02 ILS/shares for the 3-month period ending 2022-06-30, per its 6-K/A filed 2022-08-29.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShare · last filed 2022-08-29
- SCINAI IMMUNOTHERAPEUTICS LTD. diluted earnings loss per share for the quarter ending 2020-09-30 was $0.10.
- SCINAI IMMUNOTHERAPEUTICS LTD. diluted earnings loss per share for the quarter ending 2019-09-30 was -$0.05.
USD/shares
| Period end | Diluted Earnings Loss Per Share 3 month | Diluted Earnings Loss Per Share 6 month | Diluted Earnings Loss Per Share 9 month | Diluted Earnings Loss Per Share 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$0.01 6-K/A · filed 2022-08-29 | |||
| 2021-09-30 | -$0.02 6-K/A · filed 2021-12-27 | |||
| 2020-09-30 | $0.10 6-K · filed 2021-01-28 | $0.02 6-K · filed 2021-01-28 | ||
| 2019-12-31 | -$0.33 6-K · filed 2021-01-28 | |||
| 2019-09-30 | -$0.05 6-K · filed 2021-01-28 | -$0.23 6-K · filed 2021-01-28 |
ILS/shares
| Period end | Diluted Earnings Loss Per Share 3 month | Diluted Earnings Loss Per Share 6 month | Diluted Earnings Loss Per Share 9 month | Diluted Earnings Loss Per Share 12 month |
|---|---|---|---|---|
| 2022-06-30 | -0.02 ILS/shares 6-K/A · filed 2022-08-29 | -0.03 ILS/shares 6-K/A · filed 2022-08-29 | ||
| 2021-12-31 | -0.07 ILS/shares 6-K/A · filed 2022-08-29 | |||
| 2021-09-30 | -0.02 ILS/shares 6-K/A · filed 2021-12-27 | -0.05 ILS/shares 6-K/A · filed 2021-12-27 | ||
| 2021-06-30 | -0.03 ILS/shares 6-K/A · filed 2022-08-29 | -0.04 ILS/shares 6-K/A · filed 2022-08-29 | ||
| 2020-12-31 | -0.01 ILS/shares 6-K/A · filed 2021-12-27 | |||
| 2020-09-30 | 0.10 ILS/shares 6-K/A · filed 2021-12-27 | 0.02 ILS/shares 6-K/A · filed 2021-12-27 |